Cite
VanderWeele DJ, Paner GP, Fleming GF, et al. Sustained Complete Response to Cytotoxic Therapy and the PARP Inhibitor Veliparib in Metastatic Castration-Resistant Prostate Cancer - A Case Report. Front Oncol. 2015;5:169doi: 10.3389/fonc.2015.00169.
VanderWeele, D. J., Paner, G. P., Fleming, G. F., & Szmulewitz, R. Z. (2015). Sustained Complete Response to Cytotoxic Therapy and the PARP Inhibitor Veliparib in Metastatic Castration-Resistant Prostate Cancer - A Case Report. Frontiers in oncology, 5169. https://doi.org/10.3389/fonc.2015.00169
VanderWeele, David J, et al. "Sustained Complete Response to Cytotoxic Therapy and the PARP Inhibitor Veliparib in Metastatic Castration-Resistant Prostate Cancer - A Case Report." Frontiers in oncology vol. 5 (2015): 169. doi: https://doi.org/10.3389/fonc.2015.00169
VanderWeele DJ, Paner GP, Fleming GF, Szmulewitz RZ. Sustained Complete Response to Cytotoxic Therapy and the PARP Inhibitor Veliparib in Metastatic Castration-Resistant Prostate Cancer - A Case Report. Front Oncol. 2015 Jul 22;5:169. doi: 10.3389/fonc.2015.00169. eCollection 2015. PMID: 26258074; PMCID: PMC4510409.
Copy
Download .nbib